Cargando…
A case of breast cancer: Suppression of lactation-related FDG uptake 2 days after cabergoline administration
We present a case of a 35-year-old woman with breast cancer in lactation 3 months after childbirth, in which a lactation inhibitor was useful for 18F-FDG PET/CT examination. Via ultrasonography and biopsy with histopathology, we diagnosed the lesion in the upper region of the left breast as invasive...
Autores principales: | Kuroda, Hiroyuki, Yoshizako, Takeshi, Yamamoto, Nobuko, Kataoka, Yuko, Hyakudomi, Miki, Itakura, Masayuki, Kaji, Yasushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164254/ https://www.ncbi.nlm.nih.gov/pubmed/37163201 http://dx.doi.org/10.1177/20584601231174611 |
Ejemplares similares
-
Breast 3 T-MR imaging: indication for stereotactic vacuum-assisted breast biopsy
por: Yamamoto, Nobuko, et al.
Publicado: (2014) -
Is Cabergoline Safe and Effective for Postpartum Lactation Inhibition? A Systematic Review
por: Yang, Yang, et al.
Publicado: (2020) -
Cabergoline: a review of its use in the inhibition of lactation for women living with HIV
por: Tulloch, Karen J, et al.
Publicado: (2019) -
Effects of Cabergoline administration on uterine perfusion in women with polycystic ovary syndrome
por: Mohammadbygi, Robabeh, et al.
Publicado: (2013) -
Does the timing of cabergoline administration impact rates of ovarian hyperstimulation syndrome?
por: Rubenfeld, Eryn Sara, et al.
Publicado: (2021)